ISRCTN ISRCTN72673620
DOI https://doi.org/10.1186/ISRCTN72673620
Protocol serial number N/A
Sponsor Wythenshawe Hospital (UK)
Funders Asthma UK (UK), Moulton Charitable Trust (UK)
Submission date
18/04/2006
Registration date
05/05/2006
Last edited
11/02/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Adnan Custovic
Scientific

North West Lung Research Centre
Wythenshawe Hospital
Southmoor Road
Manchester
M23 9LT
United Kingdom

Phone +44 (0)161 291 2494
Email adnan.custovic@manchester.ac.uk

Study information

Primary study designObservational
Study designProspective observational birth cohort study
Secondary study designCohort study
Study type Participant information sheet
Scientific titleManchester Asthma and Allergy Study
Study acronymMAAS
Study objectivesBirth cohort study investigating the development of asthma and allergic disease
Ethics approval(s)1. Age 0 - 5 years follow up, ERP/94/032, approval received on 24/03/1994
2. Age 5 - 8 years follow up, SOU/00/258 and SOU/00/259, approval received on 20/12/2000
3. Age 8 - 11 years follow up, 03/SM/400, approval received on 05/12/2003
Health condition(s) or problem(s) studiedAsthma and allergy
InterventionThis is a prospective, observational birth cohort study, which includes investigating environmental exposures, immune responses, behaviour or family functioning, genetic epidemiology, pulmonary physiology and clinical outcomes
Intervention typeOther
Primary outcome measure(s)

1. Asthma at age 5, 8, 11 and 14 years
2. Sensitisation at age 1, 3, 5, 8, 11 and 14 years
3. Allergies (e.g. hay fever) at age 5, 8, 11 and 14 years

Key secondary outcome measure(s)

1. Wheeze and eczema at age 1, 3, 5, 8, 11 and 14 years
2. Healthcare utilisation by age 8 - 11 years

Completion date01/06/2019

Eligibility

Participant type(s)Patient
Age groupChild
SexAll
Target sample size at registration1250
Key inclusion criteriaChildren born at Wythenshawe Hospital, Manchester and Stepping Hill Hospital, Stockport between January 1996 and April 1998
Key exclusion criteriaPremature birth <32 weeks gestation
Date of first enrolment01/09/1995
Date of final enrolment01/06/2019

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Wythenshawe Hospital
Manchester
M23 9LT
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summary
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 15/06/2008 Yes No
Results article results 01/06/2010 Yes No
Results article results 01/12/2015 Yes No
Results article results 15/10/2018 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

11/02/2019: Publication reference added.
05/05/2016: Publication reference added.